Mycoplasma pneumoniae pneumonia in a series of 10 patients;Pneumopathie a Mycoplasma pneumoniae: 10 observations

Presse Medicale

Volumn 28, Issue 2, 1999, Pages 59-66

  Lesobre, V ^a   Azarian, R ^a   Gagnadoux, F ^a   Harzic, M ^a   Pangon, B ^a   Petitpretz, P ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; DRUG CHOICE; DYSPNEA; FEMALE; FEVER; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA; RISK FACTOR; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOPLASMA PNEUMONIA; RADIOGRAPHY; RETROSPECTIVE STUDY; REVIEW;

ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITALIZATION; HUMANS; MACROLIDES; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; QUINOLONES; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033573765     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Karalus NC, Cursons RT, Leng RA et al. Community acquired pneumona : aetiology and prognostic index evaluation. Throrax 1991 ; 46:413-8.
2. Liebermar D, Schiaeffer F, Lieberman D, Horwitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community-acquired pneumonia : a review of 101 hospitalized adult patients. Respiration 1995 ; 63:261-6.
3. Mayaud C, Parrot A, Houacine S, Denis M, Akoun G. Epidémiologie des germes responsables des infections communautaires des voies respiratoires inférieures. Méd Mal infect 1992 ; 2 (spécial): 130-9.
4. Mayaud C. Epidémiologie des infections respiratoires basses aiguës de l'adulte. Röle de Chlamydia pneumoniae et de Mycoplasma pneumoniae. Presse Med 1997 ; 26:1248-53.
5. Farr BM, Kaiser DL, Harrison BDW. Connolly CK. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. Thorax 1989 ; 44:1031-5.
6. Atmar RL, Greenberg SB. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Sem Respir Infect 1989 ; 4:19-31.
7. Fernald GW, Clyde WA, Jr. Epidemic paeumonia in university students. J Adol Health Care 1989 ; 10:520-6.
8. Garo B, Carré M, Quiot JJ et al. Les aspects des infections à Mycoplasma pneumoniae. Etude multicentrique rétrospective de 182 cas. Presse Méd 1988 ; 17:1475-8.
9. Lind K, Bentzon MW. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect 1991 ; 107:189-99.
10. Luby JP. Southwestern internal medicine conference : pneumonias in adults due to mycoplasma, chlamydiae, and viruses. Am J Med 1987 ; 294:45-64.
11. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 1995 ; 162:133-42
12. Mansel JK, Rosenow EC, Smith TF, Martin JW. Mycoplasma pneumoniae pneumonia. Chest 1989 ; 95:639-46.
13. Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med 1993 ; 153:488-94.
14. Ali NJ, Sillis M, Andrews BE, Jenkins PF, Harrison BDW. The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection. Q J Med 1986 ; 58:241-51.
15. Clyde WA, Jr. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis 1993 ; 17(suppl 1):S32-6.
16. Devouassoux G, Heyraud JD, Gontier C. Infections respiratoires à Mycoplasma pneumoniae hospitalisées. Rev Mal Resp 1994 ; 11:473-7.
17. Levieil ML, Valeyre D, Tandjaoui H. Infections à Mycoplasma pneumoniae. Rev Pneumol Clin 1989 ; 45:5-13.
18. Murray HW, Masur H, Senterfit LB, Roberts RB. The protean manifestations on Mycoplasma pneumoniae infection in adults. Am J Med 1975 ; 58:229-42.
19. Stogner SW, Anderson WMD. Mycoplasmal pneumonia. Are you thinking of atypical presentations ? Postgrad Med 1990 ; 88:61-9.
20. Seggev JS, Lis I, Siman-Tov R, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 1986 ; 57:263-5.
21. Yano T, Ichikawa Y Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with intial onset of bronchial asthma. Am J Respir crit care Med 1994 ; 149:1348-53.
22. Dean NL. Mycoplasmal pneumonias in the community hospital. The "unusual" manifestations become common. Clin Chest Med 1981 ; 2:121-31.
23. Linz DH, Tolle SW, Elliot DL. Mycoplasma pneumoniae pneumonia. Experience at a referral center. West J Med 1984 ; 140:895-900.
24. Savolainen S, Jousimes-Somer H, Kleemola M, Ylikoski J. Serological evidence of viral or Mycoplasma pneumonia infection in acute maxillary sinusitis. Eur J Clin Microbiol Infect Dis 1989 ; 8:131-5.
25. Luby JP. Pneumonia caused by Mycoplasma pneumoniae infection. Clin Chest Med 1991 ; 12:237-44.
26. Charloux A, Espinassouze F, Cribier B, Quoix E, Paul, G. Multiples complications d'une infection à Mycoplasma pneumoniae. Rev Mal Resp 1993 ; 10:259-61.
27. Kalb RE, Crossman ME, Neu HC. Stevens-Johnson syndrome due to Mycoplasma Pneumoniae in an adult Am J Med 1985 ; 79:541-4.
28. Albucher JF. Lauque D, Geyer I et al. Myélite transverse induite par une infection à Mycoplasma pneumoniae. Rev Neurol 1995 ; 151:350-3
29. Couch RB. Mycoplasma pneumoniae (primary atypical pneumonia). In: Principles and practice of infectious diseases. Mandell GL, Douglas RG, Bennett JE eds. John Wiley and sons, New York 1985 ; 1065-76.
30. Morlat P, Brottier-Maroni E, Ragnaud JM, Gin H, Beauvieux JM. Aubertin J. Aspects actuels des pneumopathies à Mycoplasma pneumoniae. A propos de 38 observations. Méd Mal Infect 1987 ; 12:708-14.
31. Dawidek GMB. Anterior uveitis associated with Mycoplasma pneumoniae pneumonia. Postgrad Med J 1991 ; 67:380-2.
32. Salzman MB, Sood SK, Slavin ML, Rubin LG. Ocular manifestations of Mycoplasma pneumoniae Infection. Clin Infect Dis 1992 ; 14:1137-9.
33. Taylor-Robinson D. Infections due to species of mycoplasma and ureaplasma : an update. Clin Infect Dis 1996 ; 23:671-84.
34. Campbell JH, Warwick G, Boulton-Jones M, McLay A, Jackson B, Stevenson RD. Rapidly progressive glomerulonephritis and nephrotic syndrome associated with Mycoplasma pneumoniae pneumonia. Nephrol Dial Transplant 1991 ; 6:518-20.
35. Kanayama Y, Shiota K, Kotumi K et al. Mycoplasma pneumoniae pneumonia associated with IgA nephropathy. Scand J Infect Dis 1982 ; 14:231-3.
36. Fesq G, Laporte JP, Mellat M, Piquet J, Bignon J. A propos de 2 cas d'anémie hémolytique lors de pneumopathies à mycoplasme. Rev Pneumol Clin 1990 ; 46:83-4.
37. Finnegan OC, Fowles SJ, White RJ. Radiographic appearances of mycoplasma pneumonia. Thorax 1981 ; 36:469-72.
38. MacFarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH. Comparative radiographic features of community acquired legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. Thorax 1984 ; 39:28-33.
39. Cassell GH, Cole BC. Mycoplasmas as agents of human disease N Engl J Med 1981 ; 304:80-9.
40. Aubert G, Pozzetto B, Gaudin OG, Hafid J, Mbida AD, Ros A Evaluation of five commercial tests complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology. Ann Biol Clin 1992 ; 50:593-7.
41. Harzic M, Chaplain C, Alvarez JC, Ghnassia JC. Comparison of three methods for the detection of Mycoplasma pneumoniae antibodies (abstract). 92nd General meeting of the American Society of Microbiology 1992 ; V30:529.
42. Bebear C. Diagnostic biologique des infections respiratoires à Mycoplasma pneumoniae. Rev Mol Resp 1986 ; 3:67-71.
43. Quatrème Conférence de Consensus en Thérapeutique Anti-infectieuse de la Société de Pathologie Infectieuse de Langue Française, Lille - 18 octobre 1991. Les infections des voies respiratoires. Méd Mal Infect 1992 ; 22 (spécial):42-62.
44. McCormack WM. Susceptibility of mycoplasmas to antimicrobial agents : clinical implications. Clin Infect Dis 1993 ; 17(suppl 1):5200-1.
45. Schlick W. The problems of treating atypical preumonia. J Antimicrob Chemother 1993 ; 31 (suppl C):111-20.
46. Bebear C, Dupon M, Renaudin H, De Barbeyrac B. Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin Infect Dis 1993 ; 17 (suppl 1):S202-7.
47. Ishida K, Kaku M, Irifune K, et al. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob Agents Chemother 1994 ; 38:790-8.
48. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993 ; 17(suppl i):S37-546.
49. Kaku M, Kohno S, Koga H, Ishida K, Hara K. Efficacy of roxithromycin in the treatment of mycoplasma pneumonia. Chemotherapy 1995 ; 41:149-152.
50. Coultas DB, Samet JM, Butler C. Bronchiolitis obliterars due to Mycoplasma pneumoniae. West J Med 1986 ; 144:471-4,
51. Kaufman JM, Cuvelier CA, Van Der Straeten M. Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax 1980 ; 35:140-4.
52. Koletsky RJ, Weinstein M. Fulminant Mycoplasma pneumomae infection. Am Rev Respir Dis 1980 ; 121:491-6.
53. Wongtim S, Mogmued S. Methacholine inhalation challenge in patients with post-Mycoplasma pneumoniae pneumonia. Asian Pac J Allergy Immunol 1995 ; 13:5-10.
54. Laitinen LA, Miettinen AK, Kuosma E, Huhtala L, Lehtomaki K. Lung function impairment followng mycoplasmal and other acute pneumonias. Eur Respir J 1992 ; 5:670-4.
55. Tablan OC, Reyes MP, Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. Am J Med 1985 ; 79:268-70.
56. Goudie BM, Kerr MR, Johnson RN. Mycoplasma pneumonia complicated by bronchiectasis. J Infect 1983 ; 7:151-2.